Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01807754 · ClinicalTrials.gov registry record
Simulated Screening Study for Breast Imaging
A clinical trial of Breast Tumors and Breast Cysts, sponsored by University of Michigan.
- Completed
- Registry status
- 41
- Enrollment target
- 1
- Study location
NCT01807754 is a study of Breast Tumors and Breast Cysts that has completed, run by University of Michigan. The registered enrollment target is 41 participants, below the 1,707-participant average among 3 other Breast Tumors trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01807754, a study of Breast Tumors and Breast Cysts, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot, simulated breast cancer screening study. The goal of the study is to explore these scanning modalities: 1\) Combined digital breast tomosynthesis(DBT)/dual-sides 3 dimensional-automated ultrasound(AUS) 2\. Explore the utility of photoacoustic imaging as an adjunct to digital breast tomosynthesis(DBT)/ultrasound(US)alone.
Conditions Studied
Interventions
- PROCEDURE X-ray and ultrasound imaging scanning
- PROCEDURE Photoacoustic imaging scans for breast cancer screening
Study Locations (1)
Michigan
- University of Michigan Hospital - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-12 |
| Est. Completion | 2020-04-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01807754
The ClinicalTrials.gov registry entry for NCT01807754 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,707-participant average among 3 other Breast Tumors trials with a reported enrollment target (98% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Tumors appearing as the primary indexed condition, and to 2 interventions - of which X-ray and ultrasound imaging scanning is the first listed.
NCT01807754 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01807754 about?
NCT01807754 is a clinical study titled "Simulated Screening Study for Breast Imaging". This is a pilot, simulated breast cancer screening study. The goal of the study is to explore these scanning modalities: 1\) Combined digital breast tomosynthesis(DBT)/dual-sides 3 dimensional-automated ultrasound(AUS) 2\. Explore the utility of photoacoustic imaging as an adjunct to digital breas...
What is the current status of trial NCT01807754?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2012-12. Estimated completion is 2020-04-23.
What conditions does trial NCT01807754 study?
This clinical trial studies the following conditions: Breast Tumors, Breast Cysts.
What interventions are being tested in trial NCT01807754?
The interventions under investigation include: X-ray and ultrasound imaging scanning (PROCEDURE), Photoacoustic imaging scans for breast cancer screening (PROCEDURE).
Who is sponsoring clinical trial NCT01807754?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01807754 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RECRUITING · Phase 2
-
Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer
COMPLETED · NA
-
Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.